Why Portugal Works for Biotech / Life Sciences
Funding access (95/100) is a standout for Portugal Biotech / Life Sciences companies. The local market has 48 active VC funds, with average seed checks of $700K. Government grant programs include Startup Portugal Voucher ($15K) and Portugal 2030 (FEDER) ($200K). Non-dilutive capital availability reduces the pressure to give up equity at early stage, which is particularly valuable for capital-efficient Biotech / Life Sciences businesses.
Family viability (95/100) is a genuine strength for Portugal - important for Biotech / Life Sciences founders relocating with a partner or children. The cost of living index is 68 (NYC = 100), with a comfortable family monthly budget of $5K. Safety scores 82/100. International schools are available, and healthcare quality scores 76/100 with private insurance running approximately $280/month.
Operational ease (91/100) makes Portugal practical for Biotech / Life Sciences founders setting up from scratch. Banking difficulty for foreigners is rated moderate. Company formation takes approximately 3 days at a cost of around $500, with annual compliance costs around $2K. Full foreign ownership is permitted - no local partner required. IP protection quality is rated moderate, which matters for Biotech / Life Sciences businesses with proprietary technology or brand assets.